You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Semaglutide

Showing 26 - 50 of 362
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Diabetes, Type 2 Trial in Shanghai (semaglutide injection)

Active, not recruiting
  • Diabetes Mellitus, Type 2
  • semaglutide injection
  • Shanghai, Shanghai, China
    Zhongshan Hospital
Apr 13, 2023

Atherosclerosis, Cardiovascular Diseases, Diabetes, Type 2 Trial in North York, Scarborough (Semaglutide Pen Injector)

Recruiting
  • Atherosclerosis
  • +3 more
  • Semaglutide Pen Injector
  • North York, Ontario, Canada
  • +1 more
May 12, 2023

Fibrosis, Liver, Type 2 Diabetes in Obese, Non-Alcoholic Fatty Liver Disease Trial in La Jolla (Semaglutide, Placebo)

Recruiting
  • Fibrosis, Liver
  • +2 more
  • Semaglutide
  • Placebo
  • La Jolla, California
    University of California, San Diego
Aug 25, 2023

Brown Adipose Tissue Activity in Response to Semaglutide

Not yet recruiting
  • Obesity
  • Semaglutide Injectable Product
  • (no location specified)
Jan 17, 2023

Polycystic Ovary Syndrome Trial in Hull (Metformin, Semaglutide Injectable Product)

Not yet recruiting
  • Polycystic Ovary Syndrome
  • Hull, United Kingdom
    Hull University Teaching Hospitals NHS Trust
Dec 1, 2022

Diabetes, Type 2, Stroke (CVA) or Transient Ischemic Attack Trial in Seattle (Semaglutide Auto-Injector, Placebo)

Not yet recruiting
  • Diabetes Mellitus, Type 2
  • Stroke (CVA) or Transient Ischemic Attack
  • Semaglutide Auto-Injector
  • Placebo
  • Seattle, Washington
    University of Washington - Harborview Medical Center
Mar 10, 2023

Alcohol Abuse, Alcohol Addiction, Alcohol Dependence Trial in Frederiksberg (Semaglutide Injectable Product, Placebo)

Recruiting
  • Alcohol Abuse
  • +3 more
  • Semaglutide Injectable Product
  • Placebo
  • Frederiksberg, Denmark
    Psychiatric Center Copenhagen, Frederiksberg Hospital
Jun 13, 2023

Diabetes, Type 2, Healthy Participants Trial in Cypress (Semaglutide B, 1.34 mg/mL, Semaglutide B, 0.68 mg/mL)

Not yet recruiting
  • Diabetes Mellitus, Type 2
  • Healthy Participants
  • Semaglutide B, 1.34 mg/mL
  • Semaglutide B, 0.68 mg/mL
  • Cypress, California
    Novo Nordisk Investigational Site
Jan 9, 2023

Healthy Volunteers Trial in Berlin (Semaglutide, Dapagliflozin, Semaglutide/dapagliflozin)

Recruiting
  • Healthy Volunteers
  • Semaglutide
  • +2 more
  • Berlin, Brandenburg, Germany
    Novo Nordisk Investigational Site
Aug 10, 2022

ive Alzheimer's Medicines (DREAM)- Semaglutide v DPP4 Inhibitors

Active, not recruiting
  • Diabetes
  • Semaglutide
  • DPP-4 inhibitor
  • Boston, Massachusetts
    Brigham and Women's Hospital
Mar 3, 2023

Diabetes, Type 2 Trial in Pembroke Pines (Semaglutide J, Semaglutide B)

Not yet recruiting
  • Diabetes Mellitus, Type 2
  • Semaglutide J
  • Semaglutide B
  • (no location specified)
Aug 10, 2022

Diabetes, Type 2 Trial in Austria, Denmark, Sweden (Semaglutide, Placebo (semaglutide))

Active, not recruiting
  • Diabetes Mellitus, Type 2
  • Semaglutide
  • Placebo (semaglutide)
  • Graz, Austria
  • +3 more
Dec 5, 2022

Healthy Participants Trial in Montreal (Semaglutide)

Recruiting
  • Healthy Participants
  • Semaglutide
  • Montreal, Quebec, Canada
    Novo Nordisk Investigational Site
Oct 18, 2023

Type 2 Diabetes, End Stage Renal Disease on Dialysis Trial in Chapel Hill (Semaglutide, Placebo)

Not yet recruiting
  • Type 2 Diabetes
  • End Stage Renal Disease on Dialysis
  • Semaglutide
  • Placebo
  • Chapel Hill, North Carolina
    University of North Carolina
Sep 11, 2023

PreDiabetes, Prediabetic State, Obesity Trial in Bialystok (Semaglutide Pill)

Recruiting
  • PreDiabetes
  • +2 more
  • Semaglutide Pill
  • Bialystok, Podlaskie, Poland
    Clinical Research Centre, Medical University of Bialystok
Nov 2, 2022

Obesity, Diabetes, Metabolic Syndrome Trial in London (Semaglutide 3 mg, Placebo)

Recruiting
  • Obesity
  • +2 more
  • Semaglutide 3 mg
  • Placebo
  • London, United Kingdom
    UCL
Nov 3, 2022

Non-alcoholic Fatty Liver Disease Trial in Zagazig (Rybelsus Oral Product, Ozempic Injectable Product, Tocopherol and/or Actos)

Recruiting
  • Non-alcoholic Fatty Liver Disease
  • Rybelsus Oral Product
  • +2 more
  • Zagazig, Sharkia, Egypt
    Zagazig University
Apr 1, 2023

Healthy Volunteers, Diabetes, Type 2, Overweight Trial in Groningen (Semaglutide, Dulaglutide)

Completed
Has Results
  • Healthy Volunteers
  • +3 more
  • Groningen, Netherlands
    Novo Nordisk Investigational Site
Nov 4, 2022

Diabetes, Type 2 Trial (Semaglutide, Empagliflozin)

Withdrawn
  • Diabetes Mellitus, Type 2
  • (no location specified)
Nov 11, 2022

Healthy, Obesity Trial (BI 1820237, semaglutide, Placebo)

Not yet recruiting
  • Healthy
  • Obesity
  • BI 1820237
  • +3 more
  • (no location specified)
Mar 6, 2023

Acute Ischemic Stroke Trial in Aarhus (Semaglutide, Standard care)

Not yet recruiting
  • Acute Ischemic Stroke
  • Semaglutide
  • Standard care
  • Aarhus, Denmark
    Aarhus University Hospital
Dec 9, 2022

Alzheimer, Mild Cognitive Impairment, Metabolic Syndrome Trial in Ramat Gan (Semaglutide, Intranasal insulin, Semaglutide )

Not yet recruiting
  • Alzheimer Disease
  • +2 more
  • Semaglutide
  • +3 more
  • Ramat Gan, Israel
    Joseph Sagol Neuroscience center, Sheba Medical Center
Oct 3, 2023

Overweight, Obesity Trial in China (Semaglutide, Semaglutide Placebo)

Not yet recruiting
  • Overweight
  • Obesity
  • Semaglutide
  • Semaglutide Placebo
  • Beijing, Beijing, China
  • +14 more
May 26, 2023

Obesity, Weight Loss Trial in Hyderabad (oral semaglutide)

Recruiting
  • Obesity
  • Weight Loss
  • oral semaglutide
  • Hyderabad, Telangana, India
    Asian Institute of Gastroenterology hospitals
Jul 18, 2022

Cardiomyopathy, Heart Failure With Preserved Ejection Fraction (HFpEF), Obesity Trial in Rochester (Semaglutide, Placebo,

Recruiting
  • Cardiomyopathy
  • +2 more
  • Semaglutide
  • +2 more
  • Rochester, Minnesota
    Mayo Clinic in Rochester
Jan 3, 2023